The Central Drugs Standards Control Organisation (CDSCO) flagged over 50 common drugs, including paracetamol and Pan-D, as “not of standard quality” (NSQ). This follows routine testing by state drug officers. Notable failures include Glimepiride and Telmisartan, manufactured by major companies. The list underscores the need for increased regulatory scrutiny to ensure patient safety.